Data Foundry

Drug recalls 2019

Carvedilol Tablets — Class III drug recall D-1242-2019

Terminated recall by Zydus Pharmaceuticals USA Inc, reported 2019-05-01, distributed nationwide. Presence of Foreign Tablets/Capsules: Customer complaint for a small, solid, light yellow substance, identifie

Recall numberD-1242-2019
Product typeDrug
ClassificationClass III
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmZydus Pharmaceuticals USA Inc, Pennington, NJ, United States
Recall initiated2019-04-22
Classified2019-04-25
Reported by FDA2019-05-01
Terminated2021-01-14
DistributedNationwide (US)
Quantity7,668 bottles
NDC68382-0092, 68382-0092-01, 68382-0092-05, 68382-0092-17, 68382-0093, 68382-0093-01, 68382-0093-05, 68382-0093-17, 68382-0094, 68382-0094-01, 68382-0094-05, 68382-0094-17, 68382-0095, 68382-0095-01, 68382-0095-05, 68382-0095-17
Lot numbersZ803518
Expiration dates2020-08

Product

Carvedilol Tablets, USP, 3.125 mg, 500-count bottle, Rx Only, Manufactured by: Cadila Healthcare Ltd., India; Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534; NDC 68382-092-05

Reason for recall

Presence of Foreign Tablets/Capsules: Customer complaint for a small, solid, light yellow substance, identified as a fragmented tablet of another drug product, found mixed with tablets in a bottle of Carvedilol tablets 3.125mg.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1242-2019. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.